As diseases continue to adapt, the realm of medical diagnostics must intelligently progress to adeptly combat these changes. Timely interventions and treatments are crucial to improve patient outcomes and survival rates. There are approximately 14 medical diagnostics companies listed on the ASX, striving to pioneer the early detection of new diseases and make significant progress
Read More
An on-site death, legal disputes and global ambitions—Saferoads’s (ASX: SRH) FY23 has been eventful, to say the least. Based on its latest unaudited accounts for FY23, the road safety solutions company has survived its crash test financially. The Company generated revenue (excluding government grants) of $14.66 million, marking a 19% increase compared to FY22. EBITDA
Read More
Sure, the best perk for a shareholder would be getting a big bang for their buck. Little feels better than a major ROI, but it doesn’t hurt to give your shareholders that extra incentive to stay on board—especially if times get rough. In that spirit, gym and health club operator Viva Leisure (ASX: VVA) has
Read More
The XJO is expected to open lower this morning following a pullback in the U.S overnight. We are likely to test and hold key support at roughly 7,280 to 7,300 this morning. U.S futures have moved into the green and if they remain so during our session today it may translate to most of our
Read More
After changing its name and identity, cannabis and psychedelics provider Melodiol (ASX: ME1) has decided to sell off two of its most prominent business units, Sierra Sage Herbs and Halucenex Life Sciences to US-based Panacea Life Sciences for $7.56 million in cash and shares. Panacea Life Sciences focuses on the production, research, and distribution of
Read More
After undertaking significant capital raising and promising about five-times its 2021 EBITDA, tertiary education company EDU Holdings (ASX: EDU) has decided to terminate its acquisition agreement with the Nurse Training Australia (NTA). The $6 million acquisition, initially disclosed on June 2, 2022, hinged on NTA obtaining reaccreditation for its Diploma of Nursing program from the
Read More